The Deutsche Apotheker- und Ärztebank (apoBank) has announced a significant shift in its capital market strategy for 2025. Germany’s largest cooperative primary bank is adopting a more defensive investment approach, moving from a “neutral” stance on equities to an “underweight” position. Simultaneously, apoBank is increasing its allocation to bonds, shifting to an “overweight” stance.
“The outlook for equities is less promising next year, with risk premiums becoming less attractive,” stated Reinhard Pfingsten, Chief Investment Officer (CIO) of apoBank. “While the economic environment remains supportive of stable earnings growth, risks have increased. These stem from political uncertainties and high stock market valuations, which are driven by the overly optimistic sentiment of many investors.” Pfingsten further noted that apoBank expects central banks to reduce interest rates faster than the market anticipates, which underpins their positive outlook on government bonds. “As a result, we are increasing our investment quota for fixed-income securities,” he added.
Global Economic Outlook: Resilient Growth Continues
The global economy’s backdrop remains favorable for international financial markets. Inflation, which surged during the COVID-19 pandemic and the Russia-Ukraine conflict, is on a steady decline and, in some cases, has returned to levels last seen five years ago. Against this backdrop, apoBank forecasts solid global growth in 2025, surpassing the potential growth rate of approximately 2.5%.
The United States is expected to continue its growth leadership among major economies, marking the third consecutive year of outperformance. Analysts predict that the U.S. will significantly exceed average growth expectations, driven in part by tax reforms under President Trump’s new economic agenda. While a more restrictive trade policy may dampen private consumption, planned reductions in personal and corporate taxes are anticipated to provide a strong growth stimulus.
Germany’s Economy Lags Behind
In stark contrast, Germany’s economy is forecasted to continue its sluggish performance, dragging down overall growth in the Eurozone. Structural challenges and limited fiscal flexibility, due to the constitutional debt brake, are expected to constrain counter-cyclical fiscal policy. apoBank’s economic experts foresee Germany walking a fine line between low growth and a mild recession, mirroring the trend observed over the past two years. No significant growth impulses are anticipated from the new German government in the short term, as any fiscal policy adjustments are unlikely to materialize before the second half of 2025.
Commentary
Subscribe to get access
Read more of this content when you subscribe today.
Conclusion
apoBank’s strategy shift towards bonds and away from equities reflects a careful reassessment of risk and opportunity in 2025. With the prospect of lower central bank rates and rising uncertainties, the move is both rational and forward-looking. RATING EVIDENCE GmbH supports this approach, viewing it as a model for other financial institutions navigating a shifting economic landscape. The emphasis on bonds, amid declining inflation and potential rate cuts, offers a balanced path for growth-oriented yet risk-conscious investors.


Leave a comment